RUBICON FDA Approval ANDA 216351

ANDA 216351

RUBICON

FDA Drug Application

Application #216351

Application Sponsors

ANDA 216351RUBICON

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL1MG/ML0ARIPIPRAZOLEARIPIPRAZOLE

FDA Submissions

UNKNOWN; ORIG1AP2022-10-27STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAA

CDER Filings

RUBICON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216351
            [companyName] => RUBICON
            [docInserts] => ["",""]
            [products] => [{"drugName":"ARIPIPRAZOLE","activeIngredients":"ARIPIPRAZOLE","strength":"1MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/27\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-10-27
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.